Live: Will Aehr Test Systems Crush Tonight’s Q4 Earnings After the Market Closes?

Investing

Vertex Pharmaceuticals : VRTX

All Vertex Pharmaceuticals Articles

256 Articles

Paul Ausick | May 7, 2012 at 4:08 PM EDT

24/7 Wall St. Closing Bell (FSLR, PEP, PG, ILMN, CCL, ANV, AWR, BBEP, CDE, DISH, LPX, TSN, HFC, CHTR, DMD, HL, OMX, THC, WEN, DIS, VRTX, CTSH, BSFT)

The major US stock indexes opened lower this morning following a weekend of elections in Europe. A new Socialist party…

Jon C. Ogg | May 7, 2012 at 8:54 AM EDT

Vertex Sees Billions In Value on Cystic Fibrosis Results (VRTX)

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is trading up so much higher that you might think the company is being acquired. …

Jon C. Ogg | Apr 17, 2012 at 8:27 AM EDT

Top Analyst Upgrades & Downgrades (ACHN, AAPL, BSX, CLS, C, CTRN, FSLR, HAIN, IDIX, INFY, NCT, SAP, TNK, TIF, VLO, VRTX)

Jon OggThese are some of today’s top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Tuesday.…

Jon C. Ogg | Apr 4, 2012 at 1:28 PM EDT

Abbott’s Hep-C Pressures All Hep-C Rivals (ABT, RIGL, GILD, VRTX, IDIX)

News from Abbott Laboratories (NYSE: ABT) on its positive Phase II study results from two different interferon-free hepatitis C treatment…

Jon C. Ogg | Feb 17, 2012 at 10:33 AM EST

Gilead Defended By Analyst As Competitors Gain Momentum (GILD, BMY, VRTX, ACHN)

Gilead Sciences, Inc. (NASDAQ: GILD) has recovered from its pre-market lows on the devastating news that its Hepatitis C drug…

Jon C. Ogg | Feb 2, 2012 at 4:29 PM EST

Vertex Outlines 2012 Sales Expectations (VRTX)

Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) is trading lower after earnings, but this may be due more to a give back from…

Jon C. Ogg | Feb 1, 2012 at 3:43 PM EST

Top Earnings Previews For Thursday (BZH, PHM, BX, CME, DOW, GNW, GILD, IP, K, MA, MRK, RCL, HOT, TRMB, VRTX, YRCW)

Earnings season is still upon us. There are going to be many big earnings reports Thursday and we would consider…

Jon C. Ogg | Feb 1, 2012 at 8:18 AM EST

Top Analyst Upgrades & Downgrades (AMZN, ASH, BAC, C, CAT, DB, XOM, MWW, NEM, STX, SXC, WBSN, VRTX)

Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street brokerage and research firms…

Jon C. Ogg | Jan 31, 2012 at 11:34 AM EST

Another FDA Approval For Vertex (VRTX)

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) has announced another FDA approval. While this approval will treat cystic fibrosis, the current total…

Jon C. Ogg | Jan 10, 2012 at 3:47 PM EST

Achillion Pharma, Too Much of a Good Thing After 50% Gain? (ACHN, MRK, GILD, VRUS, BMY, INHX, VRTX)

Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) has been on fire due to the rapid interest of hepatitis C treatments and the bidding of…

Jon C. Ogg | Jan 9, 2012 at 11:11 AM EST

Hepatitis-C to the Moon (BMY, INHX, ACHN, IDIX, VRTX)

You know how stocks sometimes react to news on peers… Today we are again seeing a run in the world…

Jon C. Ogg | Jan 4, 2012 at 8:01 AM EST

Tracking Dividends in Biotech: Who Follows Amgen in Payouts? (AMGN, PFE, MRK, BIIB, CELG, ALXN, CBST, PDLI, REGN, VRTX)

For several years it has been the case that Amgen Inc. (NASDAQ: AMGN) was considered a biotech though it had at…

Jon C. Ogg | Dec 14, 2011 at 9:05 AM EST

Top Analyst Upgrades & Downgrades (MO, AVP, CE, LFC, EL, FITB, GE, MIND, VRTX, YHOO, YUM, GRPN)

Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Wednesday…

Jon C. Ogg | Nov 21, 2011 at 9:22 AM EST

Hepatitis C Makers Mostly Higher on Gilead/Pharmasset M&A (IDIX, INHX, VRTX)

The deal between Gilead and Phamasset is driving other hepatitis C developers higher this morning. Whether the 90% or so premium…

Jon C. Ogg | Nov 12, 2011 at 9:19 AM EST

24/7 Wall St. Top Analyst Calls of the Week (ALU, AMZN, AAPL, CSCO, CSC, CXW, DF, EPD, GNW, GMCR, GRPN, HD, MPEL, PIR, SRDX, TEVA, VRTX, YRCW, ALIM)

Each morning 24/7 Wall St. issues a summary list of key analyst upgrades, downgrades, and initiations issued by Wall Street…

1 … 13 14 15 16 17 18

Vertex Pharmaceuticals : VRTX

All Vertex Pharmaceuticals Articles

24/7 Wall St. Closing Bell (FSLR, PEP, PG, ILMN, CCL, ANV, AWR, BBEP, CDE, DISH, LPX, TSN, HFC, CHTR, DMD, HL, OMX, THC, WEN, DIS, VRTX, CTSH, BSFT)

Vertex Sees Billions In Value on Cystic Fibrosis Results (VRTX)

Top Analyst Upgrades & Downgrades (ACHN, AAPL, BSX, CLS, C, CTRN, FSLR, HAIN, IDIX, INFY, NCT, SAP, TNK, TIF, VLO, VRTX)

Abbott’s Hep-C Pressures All Hep-C Rivals (ABT, RIGL, GILD, VRTX, IDIX)

Gilead Defended By Analyst As Competitors Gain Momentum (GILD, BMY, VRTX, ACHN)

Vertex Outlines 2012 Sales Expectations (VRTX)

Top Earnings Previews For Thursday (BZH, PHM, BX, CME, DOW, GNW, GILD, IP, K, MA, MRK, RCL, HOT, TRMB, VRTX, YRCW)

Top Analyst Upgrades & Downgrades (AMZN, ASH, BAC, C, CAT, DB, XOM, MWW, NEM, STX, SXC, WBSN, VRTX)

Another FDA Approval For Vertex (VRTX)

Achillion Pharma, Too Much of a Good Thing After 50% Gain? (ACHN, MRK, GILD, VRUS, BMY, INHX, VRTX)

Hepatitis-C to the Moon (BMY, INHX, ACHN, IDIX, VRTX)

Tracking Dividends in Biotech: Who Follows Amgen in Payouts? (AMGN, PFE, MRK, BIIB, CELG, ALXN, CBST, PDLI, REGN, VRTX)

Top Analyst Upgrades & Downgrades (MO, AVP, CE, LFC, EL, FITB, GE, MIND, VRTX, YHOO, YUM, GRPN)

Hepatitis C Makers Mostly Higher on Gilead/Pharmasset M&A (IDIX, INHX, VRTX)

24/7 Wall St. Top Analyst Calls of the Week (ALU, AMZN, AAPL, CSCO, CSC, CXW, DF, EPD, GNW, GMCR, GRPN, HD, MPEL, PIR, SRDX, TEVA, VRTX, YRCW, ALIM)

Live: Will Aehr Test Systems Crush Tonight’s Q4 Earnings After the Market Closes?

YMAX’s 1.33% Fee Is Just the Start: How a Fund-of-Funds Structure Is Quietly Stacking Costs on Top of Costs

How a Couple With $1 Million in Retirement Can Build a Tax-Efficient $2,392 Monthly Income Stream Using 2 Vanguard ETFs

Earned Over $145,000 Last Year? Your 401(k) Catch-Up Money Is Now Forced Into a Roth and Here’s Who Wins

Earned Over $145,000 Last Year? Your 401(k) Catch-Up Money Is Now Forced Into a Roth and Here's Who Wins

She Claimed Social Security at 62 and Regretted It Within the Year. One Form Let Her Take It All Back

YMAX’s 1.33% Fee Is Just the Start: How a Fund-of-Funds Structure Is Quietly Stacking Costs on Top of Costs

How a Couple With $1 Million in Retirement Can Build a Tax-Efficient $2,392 Monthly Income Stream Using 2 Vanguard ETFs

Vertex Pharmaceuticals : VRTX

All Vertex Pharmaceuticals Articles

24/7 Wall St. Closing Bell (FSLR, PEP, PG, ILMN, CCL, ANV, AWR, BBEP, CDE, DISH, LPX, TSN, HFC, CHTR, DMD, HL, OMX, THC, WEN, DIS, VRTX, CTSH, BSFT)

Vertex Sees Billions In Value on Cystic Fibrosis Results (VRTX)

Top Analyst Upgrades & Downgrades (ACHN, AAPL, BSX, CLS, C, CTRN, FSLR, HAIN, IDIX, INFY, NCT, SAP, TNK, TIF, VLO, VRTX)

Abbott’s Hep-C Pressures All Hep-C Rivals (ABT, RIGL, GILD, VRTX, IDIX)

Gilead Defended By Analyst As Competitors Gain Momentum (GILD, BMY, VRTX, ACHN)

Vertex Outlines 2012 Sales Expectations (VRTX)

Top Earnings Previews For Thursday (BZH, PHM, BX, CME, DOW, GNW, GILD, IP, K, MA, MRK, RCL, HOT, TRMB, VRTX, YRCW)

Top Analyst Upgrades & Downgrades (AMZN, ASH, BAC, C, CAT, DB, XOM, MWW, NEM, STX, SXC, WBSN, VRTX)

Another FDA Approval For Vertex (VRTX)

Achillion Pharma, Too Much of a Good Thing After 50% Gain? (ACHN, MRK, GILD, VRUS, BMY, INHX, VRTX)

Hepatitis-C to the Moon (BMY, INHX, ACHN, IDIX, VRTX)

Tracking Dividends in Biotech: Who Follows Amgen in Payouts? (AMGN, PFE, MRK, BIIB, CELG, ALXN, CBST, PDLI, REGN, VRTX)

Top Analyst Upgrades & Downgrades (MO, AVP, CE, LFC, EL, FITB, GE, MIND, VRTX, YHOO, YUM, GRPN)

Hepatitis C Makers Mostly Higher on Gilead/Pharmasset M&A (IDIX, INHX, VRTX)

24/7 Wall St. Top Analyst Calls of the Week (ALU, AMZN, AAPL, CSCO, CSC, CXW, DF, EPD, GNW, GMCR, GRPN, HD, MPEL, PIR, SRDX, TEVA, VRTX, YRCW, ALIM)

Live: Will Aehr Test Systems Crush Tonight’s Q4 Earnings After the Market Closes?

YMAX’s 1.33% Fee Is Just the Start: How a Fund-of-Funds Structure Is Quietly Stacking Costs on Top of Costs

How a Couple With $1 Million in Retirement Can Build a Tax-Efficient $2,392 Monthly Income Stream Using 2 Vanguard ETFs

Earned Over $145,000 Last Year? Your 401(k) Catch-Up Money Is Now Forced Into a Roth and Here’s Who Wins

Featured Reads

Earned Over $145,000 Last Year? Your 401(k) Catch-Up Money Is Now Forced Into a Roth and Here's Who Wins

She Claimed Social Security at 62 and Regretted It Within the Year. One Form Let Her Take It All Back